HIV BREAKTHROUGH DRUG LICENSING DEAL MARKS SIGNIFICANT BUT FLAWED STEP FOR ACCESS

Source :: States News Service. October 2, 2024
Publication Year :: 2024
Abstract: WASHINGTON, DC -- The following information was released by Public Citizen: Today, Gilead Sciences announced a licensing deal authorizing six generics manufacturers to sell the breakthrough HIV treatment lenacapavir in [...]

Subjects :: Gilead Sciences Inc. -- Licensing agreements
Biological products industry -- Licensing agreements
HIV (Viruses)
Generic drugs -- Licensing agreements
AIDS treatment
Company licensing agreement
News, opinion and commentary

Tools